Print    
MEDIA CONTACT:
Jennifer Rossi, Ph. D
Director of Marketing and Corporate Communications
BIOCIUS Life Sciences
+1 781-928-2779

Home Page / News and Events / Press Releases ...

Recent Press Releases

 

BIOCIUS and BlueSky BioTech Team Up to Provide Industry's First Fully-Validated, Label-fee SIRT1 Assay

BIOCIUS and Agilent Partner to Launch RF360 High Resolution Accurate Mass System, Fastest Approach to ADME Screening Applications

BIOCIUS Continues Expansion in Europe to Support Growing Overseas Client Base

BIOCIUS Life Sciences Announces New Global Headquarters, Doubles Capacity

BIOCIUS Signs Distributor Agreement with Wako, Making RapidFire Instruments and Contract Research Services Available to Japanese Market

BIOCIUS Completes Strategic Spin-Out from BioTrove

BioTrove RapidFire Business Unit to Become BIOCIUS Life Sciences

BioTrove Installs First European RapidFire® System at Boehringer Ingelheim and Obtains CE Mark for the Instrument

BioTrove Presents Data Using Agilent’s Time-of-Flight MS System at American Society for Mass Spectrometry Conference (ASMS)

BioTrove Launches RapidFire 300 for in vitro ADME Discovery

GlaxoSmithKline Accelerates Research with BioTrove’s RapidFire® Mass Spectrometry System at Two Key U.S. R&D Sites

Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies

 

 

BIOCIUS. Faster Answers.

RapidFire® technology is described in patent numbers 6,932,939, 6,812,030 7,100,460, 7,588,725,